PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Stupp, Roger ^{[1
,2
]}

Idbaih, Ahmed ^{[3
]}

Steinberg, David M. ^{[4
]}

Read, William ^{[5
]}

Toms, Steven ^{[6
]}

Barnett, Gene ^{[7
]}

Nicholas, Garth ^{[8
]}

Kim, Chae-Yong ^{[9
]}

Fink, Karen ^{[10
]}

Salmaggi, Andrea ^{[11
]}

Lieberman, Frank ^{[12
]}

Zhu, Jay ^{[13
]}

Taylor, Lynne ^{[14
]}

Stragliotto, Giuseppe ^{[15
]}

Hottinger, Andreas ^{[16
]}

Kirson, Eilon D. ^{[17
]}

Weinberg, Uri

Palti, Yoram ^{[17
]}

Hegi, Monika E. ^{[16
]}

Ram, Zvi ^{[18
]}

机构：

[1] Univ Hosp Zurich, Zurich, Switzerland

[2] Univ Zurich, Zurich, Switzerland

[3] Grp Hosp Pitie Salpetriere, Paris, France

[4] Tel Aviv Univ, Tel Aviv, Israel

[5] Emory Univ Hosp Midtown, Atlanta, GA USA

[6] Geisinger Med Ctr, Danville, PA 17822 USA

[7] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[8] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[9] Seoul Natl Univ Bundang, Seoul, South Korea

[10] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA

[11] Ist Natl Neurol Carlo Besta, Milan, Italy

[12] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[13] Mem Hermann Hosp, Houston, TX USA

[14] Tufts Med Ctr, Boston, MA USA

[15] Karolinska Hosp, Stockholm, Sweden

[16] CHU Vaudois, Lausanne, Switzerland

[17] Novocure Ltd, Haifa, Israel

[18] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LTBK-01

引用

页码：1 / 1

页数：1

共 50 条

[21] Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Stupp, Roger
Taillibert, Sophie
Kanner, Andrew A.
Kesari, Santosh
Steinberg, David M.
Toms, Steven A.
Taylor, Lynne P.
Lieberman, Frank
Silvani, Antonio
Fink, Karen L.
Barnett, Gene H.
Zhu, Jay-Jiguang
Henson, John W.
Engelhard, Herbert H.
Chen, Thomas C.
Tran, David D.
Sroubek, Jan
Iran, Nam D.
Hottinger, Andreas F.
Landolfi, Joseph
Desai, Rajiv
Caroli, Manuela
Kew, Yvonne
Honnorat, Jerome
Idbaih, Ahmed
Kirson, Eilon D.
Weinberg, Uri
Palti, Yoram
Hegi, Monika E.
Ram, Zvi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (23): : 2535 - 2543
[22] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Lazaridis, Lazaros
Schaefer, Niklas
Kebir, Sied
Weller, Johannes
Tzaridis, Theophilos-Dimitrios
Scheffler, Bjoern
Pierscianek, Daniela
Kleinschnitz, Christoph
Stuschke, Martin
Sure, Ulrich
Herrlinger, Ulrich
Glas, Martin
NEURO-ONCOLOGY, 2018, 20 : 119 - 120
[23] RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Wang, Yang
Wu, Jingsong
Qin, Zhiyong
Wang, Enmin
Yao, Yu
Zhuang, Dongxiao
Liang, Lipin
Ni, Chunxia
Lu, Peijiang
Chen, Shu
Li, Chao
NEURO-ONCOLOGY, 2021, 23 : 72 - 72
[24] Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
Lazaridis, L.
Kebir, S.
Weller, J.
Tzaridis, T. -D
Scheffler, B.
Pierscianek, D.
Kleinschnitz, C.
Stuschke, M.
Sure, U.
Herrlinger, U.
Schaefer, N.
Glas, M.
STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S109 - S109
[25] PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE plus /- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA
Shi, Wenyin
Kleinberg, Lawrence
Jeyapalan, Suriya A.
Goldlust, Samuel
Nagpal, Seema
Combs, Stephanie E.
Roberge, David
Nishigawa, Ryo
Grossman, Rachel
Glas, Martin
NEURO-ONCOLOGY, 2020, 22 : 59 - 60
[26] Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
Miller, Ryan
Song, Andrew
Ali, Ayesha
Niazi, Muneeb
Bar-Ad, Voichita
Martinez, Nina
Glass, Jon
Alnahhas, Iyad
Andrews, David
Judy, Kevin
Evans, James
Farrell, Christopher
Werner-Wasik, Maria
Chervoneva, Inna
Ly, Michele
Palmer, Joshua
Liu, Haisong
Shi, Wenyin
FRONTIERS IN ONCOLOGY, 2022, 12
[27] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Lazaridis, L.
Schaefer, N.
Kebir, S.
Weller, J.
Tzaridis, T.
Schaeffler, B.
Pierscianek, D.
Kleinschnitz, C.
Stuschke, M.
Sure, U.
Herrlinger, U.
Glas, M.
NEURO-ONCOLOGY, 2018, 20 : 230 - 230
[28] COMPLIANCE AND TREATMENT DURATION PREDICT SURVIVAL IN A PHASE 3 EF-14 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Ram, Zvi
Kim, Chae-Yong
Nicholas, Garth A.
Toms, Steven
NEURO-ONCOLOGY, 2017, 19 : 6 - 7
[29] NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH GLIOBLASTOMA
Sim, Hao-Wen
Lwin, Zarnie
Barnes, Elizabeth
McDonald, Kerrie
Yip, Sonia
Verhaak, Roel
Heimberger, Amy
Hall, Merryn
Wong, Matthew
Jennens, Ross
Ashley, David
Rosenthal, Mark
Hovey, Elizabeth
Ellingson, Benjamin
Tognela, Annette
Gan, Hui
Back, Michael
Koh, Eng-Siew
Long, Anne
Cuff, Katharine
Begbie, Stephen
Gedye, Craig
Mislang, Anna
Le, Hien
Johnson, Margaret
Kong, Benjamin
Simes, John
Khasraw, Mustafa
NEURO-ONCOLOGY, 2022, 24 : 65 - 65
[30] NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
Sim, Hao-Wen
Wachsmuth, Luke
Barnes, Elizabeth H.
Yip, Sonia
Koh, Eng-Siew
Hall, Merryn
Jennens, Ross
Ashley, David M.
Verhaak, Roel G.
Heimberger, Amy B.
Rosenthal, Mark A.
Hovey, Elizabeth J.
Ellingson, Benjamin M.
Tognela, Annette
Gan, Hui K.
Wheeler, Helen
Back, Michael
Mcdonald, Kerrie L.
Long, Anne
Cuff, Katharine
Begbie, Stephen
Gedye, Craig
Mislang, Anna
Le, Hien
Johnson, Margaret O.
Kong, Benjamin Y.
Simes, John R.
Lwin, Zarnie
Khasraw, Mustafa
NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)

← 1 2 3 4 5 →